Mizuho Issues Positive Forecast for BrightSpring Health Services (NASDAQ:BTSG) Stock Price

BrightSpring Health Services (NASDAQ:BTSG) had its price target lifted by Mizuho from $17.00 to $20.00 in a report issued on Monday, Benzinga reports. Mizuho currently has an outperform rating on the stock.

A number of other equities research analysts have also recently commented on BTSG. Guggenheim lifted their price target on shares of BrightSpring Health Services from $15.00 to $18.00 and gave the stock a “buy” rating in a report on Tuesday, October 1st. The Goldman Sachs Group lowered their target price on BrightSpring Health Services from $21.00 to $18.00 and set a “buy” rating on the stock in a research note on Friday, August 9th. KeyCorp started coverage on BrightSpring Health Services in a research note on Friday, October 11th. They set a “sector weight” rating for the company. BTIG Research upped their price objective on shares of BrightSpring Health Services from $15.00 to $20.00 and gave the company a “buy” rating in a report on Thursday, October 3rd. Finally, UBS Group increased their target price on shares of BrightSpring Health Services from $16.00 to $20.00 and gave the stock a “buy” rating in a research report on Wednesday, October 30th. One analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $16.79.

BrightSpring Health Services Stock Down 2.6 %

BTSG stock opened at $16.81 on Monday. The stock has a market cap of $2.88 billion and a P/E ratio of -64.65. The company has a current ratio of 1.33, a quick ratio of 1.00 and a debt-to-equity ratio of 1.62. The stock’s fifty day simple moving average is $14.66 and its two-hundred day simple moving average is $12.52. BrightSpring Health Services has a 1-year low of $7.85 and a 1-year high of $17.54.

BrightSpring Health Services (NASDAQ:BTSG) last posted its quarterly earnings results on Friday, November 1st. The company reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.18 by ($0.07). The company had revenue of $2.91 billion for the quarter, compared to the consensus estimate of $2.72 billion. BrightSpring Health Services’s revenue for the quarter was up 28.8% on a year-over-year basis. Analysts expect that BrightSpring Health Services will post 0.57 EPS for the current year.

Insider Activity

In other BrightSpring Health Services news, major shareholder Kkr Group Partnership L.P. acquired 11,619,998 shares of the stock in a transaction that occurred on Wednesday, September 11th. The shares were bought at an average price of $11.13 per share, for a total transaction of $129,330,577.74. Following the completion of the transaction, the insider now owns 92,959,984 shares of the company’s stock, valued at approximately $1,034,644,621.92. This represents a 0.00 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Institutional Investors Weigh In On BrightSpring Health Services

Institutional investors and hedge funds have recently bought and sold shares of the stock. nVerses Capital LLC bought a new position in shares of BrightSpring Health Services in the 2nd quarter worth $55,000. Ameritas Investment Partners Inc. bought a new position in BrightSpring Health Services in the first quarter valued at $58,000. California State Teachers Retirement System purchased a new stake in BrightSpring Health Services during the first quarter valued at about $59,000. Zurcher Kantonalbank Zurich Cantonalbank purchased a new stake in BrightSpring Health Services during the second quarter valued at about $126,000. Finally, Arizona State Retirement System bought a new stake in BrightSpring Health Services during the second quarter worth about $163,000.

BrightSpring Health Services Company Profile

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.